About: Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1×, 2×, or 4×) in healthy subjects aged 70 years or older

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1×, 2×, or 4×) in healthy subjects aged 70 years or older Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 May 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2011 (uk) im Mai 2011 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 17 May 2011 (en) artículu científicu espublizáu en mayu de 2011 (ast)
publication date	wds:Q57276293-D0CD4713-7BA3-4D56-B3C5-584F93CAF918
publication date	2011-05-17 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57276293-A82AC7C6-5808-4636-BA72-95B7B77305CA
language of work or name	English
cites work	wds:Q57276293-02897CA0-D772-4E60-9963-92B4AC2EDAA3 wds:Q57276293-0996C7F5-9B4D-494B-A7EC-B577D5180127 wds:Q57276293-119879B8-314C-47AE-A095-54B1076ABA51 wds:Q57276293-14C23C9A-9906-42A8-ACD3-36C9E891765A wds:Q57276293-1C9337F2-C44E-426D-8336-72A4E37368F1 wds:Q57276293-27385CA9-5522-477C-9188-3FF27DC9C39F wds:Q57276293-2A764710-37E9-4638-9C8E-11AE2AFDD7E4 wds:Q57276293-2E7132EC-7146-456B-82D9-6AC11B0655E4 wds:Q57276293-3E50436B-53D7-48BA-AD5D-D0D7E215FDA7 wds:Q57276293-41046012-D483-4B02-848E-6D0EDBFB4453 wds:Q57276293-43C0C188-8AA4-477C-840F-ED613B61080E wds:Q57276293-49A49C2B-CC97-4E3B-8248-46B7B57C2E5C wds:Q57276293-73565262-DD2C-4451-942D-33215CA33DFE wds:Q57276293-740FFA4D-D9F9-43F4-A309-7CE7FB232774 wds:Q57276293-77B1D1F4-5CA7-470E-A948-2A2BFCDCFEA8 wds:Q57276293-7932BB20-7974-43F8-A7D8-6A950C30FCA4 wds:Q57276293-7BB1E20A-6E0F-4826-809A-D5E4BF27C83D wds:Q57276293-812FE47F-33DF-423E-8DE5-A793F6BA7779 wds:Q57276293-84583192-A96B-44DE-B2BD-248D2CF997C4 wds:Q57276293-859DD01D-F21B-4C50-8469-2A196F38AFE8 wds:Q57276293-85D9071D-E3F3-4AE7-9A54-30DB635BF4B3 wds:Q57276293-8F752104-BBAA-4C05-979F-D4A08C33DE83 wds:Q57276293-96EE85FD-7A16-4AA9-A95D-190928F55119 wds:Q57276293-9D296572-9487-4970-947B-7453F8895B05 wds:Q57276293-9F156AC4-0C0E-4ED8-9465-3425109B591C wds:Q57276293-A3C4D869-6D08-4D01-B75F-4C5A21278272 wds:Q57276293-AC4AE856-61B6-4B80-BE22-5EFE38520B3B wds:Q57276293-B0B3576B-CFEF-4571-8778-586C2AA3E68E wds:Q57276293-B0B97BCD-5385-4DEC-A4BA-D3DD785872C2 wds:Q57276293-B867E5A2-8875-44A1-A430-AF6140DBA8F0 wds:Q57276293-BBDD965A-E744-4604-B3C6-89F14D55FEBB wds:Q57276293-C066511F-8F97-4E19-B8F2-8EFDB55553F6 wds:Q57276293-C7BD086E-8E1E-42EE-B554-DE592B0A3CD0 wds:Q57276293-D91CB97A-6F64-4371-9BEC-728D3B28F0A1 wds:Q57276293-E14C70FA-66D3-45F0-9337-DC0779B38736 wds:Q57276293-E5E4D36F-D873-47EE-8783-507FC1F69380 wds:Q57276293-FEDE5238-2C2D-4154-9129-6A202F86CBF2
cites work	Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f). Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae Determining the optimal pneumococcal vaccination strategy for adults: is there a role for the pneumococcal conjugate vaccine? Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia Safety of revaccination with pneumococcal polysaccharide vaccine The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults Reconsideration of the use of meningococcal polysaccharide vaccine Pneumococcal vaccination policy in Europe Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003 Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children. Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial
author name string	wds:Q57276293-129A03C9-74C7-47D2-9DE1-433B06F6C199 wds:Q57276293-14CE800D-5AA3-4A4B-89AA-92122E6D20DC wds:Q57276293-4337E779-A767-4224-803B-C094593E776B wds:Q57276293-4C95F1EC-F68C-42D5-97E7-D12F7AA95838 wds:Q57276293-50F9679B-4DC1-48E8-ADEB-FE0F360B78A6 wds:Q57276293-737918B8-F087-4450-A0A5-72DAFC7EF0F1 wds:Q57276293-A3E7EF66-F9C3-487C-8D42-AFD16AF91188 wds:Q57276293-B7E9F1DC-2326-4079-948D-7FB348A8D499 wds:Q57276293-E9E5D497-4A9B-4E73-9530-9524E468A613 wds:Q57276293-ECA1E64A-3F2A-4641-91D1-37AB11D13974 wds:Q57276293-F2361723-60CD-46EE-95C4-2ECB1734E3B4 wds:Q57276293-FF628F40-A9AB-4171-B2BE-43EA36F55E5B
author name string	T Welte S Baker W Gruber H Lode

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 187 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software